Details for New Drug Application (NDA): 078686
✉ Email this page to a colleague
The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Summary for 078686
Tradename: | ADENOSINE |
Applicant: | Mylan Labs Ltd |
Ingredient: | adenosine |
Patents: | 0 |
Pharmacology for NDA: 078686
Mechanism of Action | Adenosine Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 078686
Suppliers and Packaging for NDA: 078686
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ADENOSINE | adenosine | INJECTABLE;INJECTION | 078686 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1631 | 51662-1631-1 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1) |
ADENOSINE | adenosine | INJECTABLE;INJECTION | 078686 | ANDA | Mylan Institutional LLC | 67457-854 | 67457-854-04 | 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-854-04) / 4 mL in 1 VIAL, SINGLE-DOSE (67457-854-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 3MG/ML | ||||
Approval Date: | May 13, 2009 | TE: | AP | RLD: | No |
Complete Access Available with Subscription